We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Hikma Pharmaceuticals

News List

Boehringer to sell stake in Hikma pharmatimes
June 24, 2020
Boehringer Ingelheim Invest has announced plans to pull its investment in Hikma Pharmaceuticals.
Hikma Pharmaceuticals extends Ketorolac Tromethamine recall in US europeanpharmaceuticalreview
March 12, 2020
The FDA has announced that Hikma are now recalling certain lots of Ketorolac Tromethamine injections at the medical facility and retail levels.
Hikma Extends Recall of Ketorolac Tromethamine Injection americanpharmaceuticalreview
March 09, 2020
Hikma Pharmaceuticals announces its subsidiary Hikma Pharmaceuticals USA Inc. (formerly known as West-Ward Pharmaceuticals) is voluntarily extending its previously-announced recall of ...
Amid FDA competition push, Hikma jacks up a handful of drug prices as much as 430% fiercepharma
August 22, 2017
West-Ward says the prices on 94% of its drugs have stayed the same or dropped this year, but prices of six drugs went up this month as much as fourfold.